Volume 9, Number 9—September 2003
Research
Epidemic and Nonepidemic Multidrug-Resistant Enterococcus faecium
Helen L. Leavis*†, Rob J.L. Willems†, Janetta Top†, Emile Spalburg†, Ellen M. Mascini*, Ad C. Fluit*, Andy Hoepelman*, Albert J. de Neeling†, and Marc J.M. Bonten*
Table 1
Description of studied Enterococcus faecium isolates
| Origin |
Country |
n |
|---|---|---|
| Vancomycin-resistant E. faecium | ||
| Epidemic |
United Kingdom |
1 |
| Netherlands |
4 |
|
| United States |
11 |
|
| Clinical infections |
Austria |
1 |
| United Kingdom |
7 |
|
| Israel |
2 |
|
| Italy |
1 |
|
| Netherlands |
8 |
|
| United States |
1 |
|
| Clinical surveillance |
Germany |
1 |
| France |
4 |
|
| United Kingdom |
1 |
|
| Israel |
1 |
|
| Italy |
1 |
|
| Netherlands |
27 |
|
| Slovenia |
1 |
|
| Community surveillance |
United Kingdom |
1 |
| Netherlands |
35 |
|
| Vancomycin-susceptible E. faecium |
||
| Clinical infections |
Austria |
6 |
| Belgium |
1 |
|
| Switzerland |
3 |
|
| Germany |
14 |
|
| Spain |
8 |
|
| France |
8 |
|
| United Kingdom |
1 |
|
| Greece |
1 |
|
| Italy |
16 |
|
| Poland |
5 |
|
| Portugal |
5 |
|
| Turkey |
5 |
|
| Clinical surveillance |
Netherlands |
5 |
| Community surveillance | Netherlands | 14 |
Page created: December 30, 2010
Page updated: December 30, 2010
Page reviewed: December 30, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.